PLIP, a Novel Splice Variant of Tip60, Interacts with Group IV Cytosolic Phospholipase A₂, Induces Apoptosis, and Potentiates Prostaglandin Production

REFERENCES

• Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389–3402.
   PubMed Web of Science ®Google Scholar
• Angel, J., F. Berenbaum, C. Le Denmat, T. Nevalainen, J. Masliah, and C. Fournier. 1994. Interleukin-1-induced prostaglandin E2 biosynthesis in human synovial cells involves the activation of cytosolic phospholipase A2 and cyclooxygenase-2. Eur. J. Biochem. 226:125–131.
   PubMedGoogle Scholar
• Atluru, D., S. Gudapaty, M. P. O'Donnell, and G. E. Woloschak. 1993. Inhibition of human mononuclear cell proliferation, interleukin synthesis, mRNA for IL-2, IL-6, and leukotriene B4 synthesis by a lipoxygenase inhibitor. J. Leukoc. Biol. 54:269–274.
   PubMedGoogle Scholar
• Atsumi, G., M. Tajima, A. Hadano, Y. Nakatani, M. Murakami, and I. Kudo. 1998. Fas-induced arachidonic acid release is mediated by Ca2+-independent phospholipase A2 but not cytosolic phospholipase A2, which undergoes proteolytic inactivation. J. Biol. Chem. 273:13870–13877.
   PubMedGoogle Scholar
• Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1995. Current protocols in molecular biology 1, John Wiley and Sons, Inc., New York, N.Y
   Google Scholar
• Baker, A. J., A. Mooney, J. Hughes, D. Lombardi, R. J. Johnson, and J. Savill. 1994. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J. Clin. Investig. 94:2105–2116.
   PubMed Web of Science ®Google Scholar
• Ben-Menahem, D., Z. Shraga-Levine, R. Limor, and Z. Naor. 1994. Arachidonic acid and lipoxygenase products stimulate gonadotropin alpha-subunit mRNA levels in pituitary alpha T3–1 cell line: role in gonadotropin releasing hormone action. Biochemistry 43:12795–12799.
   Google Scholar
• Benoit, H., M. Jordan, H. Wagner, and P. D. Wagner. 1999. Effect of NO, vasodilator prostaglandins, and adenosine on skeletal muscle angiogenic growth factor gene expression. J. Appl. Physiol. 86:1513–1518.
   PubMed Web of Science ®Google Scholar
• Bonventre, J. V.. 1992. PLA2 and signal transduction. J. Am. Soc. Nephrol. 3:128–150.
   PubMed Web of Science ®Google Scholar
• Bonventre, J. V., J. H. Gronich, and R. A. Nemenoff. 1990. Epidermal growth factor enhances glomerular mesangial cell soluble phospholipase A2 activity. J. Biol. Chem. 265:4934–4938.
   PubMedGoogle Scholar
• Bonventre, J. V., Z. Huang, M. R. Taheri, E. O'Leary, E. Li, M. A. Moskowitz, and A. Sapirstein. 1997. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390:622–625.
   PubMed Web of Science ®Google Scholar
• Bonventre, J. V., K. L. Skorecki, J. I. Kreisberg, and J. Y. Cheung. 1986. Vasopressin increases cytosolic free calcium concentration in glomerular mesangial cells. Am. J. Physiol. 251:F94–F102.
   PubMedGoogle Scholar
• Bonventre, J. V., and M. Swidler. 1988. Calcium dependency of prostaglandin E2 production in rat glomerular mesangial cells. Evidence that protein kinase C modulates the Ca2+-dependent activation of phospholipase A2. J. Clin. Investig. 82:168–176.
   PubMed Web of Science ®Google Scholar
• Bonventre, J. V., P. C. Weber, and J. H. Gronich. 1988. PAF and PDGF increase cytosolic [Ca2+] and phospholipase activity in mesangial cells. Am. J. Physiol. 254:F87–F94.
   PubMedGoogle Scholar
• Borrow, J., V. P. Stanton, J. M. Andresen, R. Becher, F. G. Behm, R. S. Chaganti, C. I. Civin, C. Disteche, I. Dube, A. M. Frischauf, D. Horsman, F. Mitelman, S. Volinia, A. E. Watmore, and D. E. Housman. 1996. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat. Genet. 14:33–41.
   PubMed Web of Science ®Google Scholar
• Brady, M. E., D. M. Ozanne, L. Gaughan, I. Waite, S. Cook, D. E. Neal, and C. N. Robson. 1999. Tip60 is a nuclear hormone receptor coactivator. J. Biol. Chem. 274:17599–17604.
   PubMed Web of Science ®Google Scholar
• Brown, D. M., and R. P. Phipps. 1996. Bcl-2 expression inhibits prostaglandin E2-mediated apoptosis in B cell lymphomas. J. Immunol. 157:1359–1370.
   PubMedGoogle Scholar
• Clark, J. D., L. L. Lin, R. W. Kriz, C. S. Ramesha, L. A. Sultzman, A. Y. Lin, N. Milona, and J. L. Knopf. 1991. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP. Cell 65:1043–1051.
   PubMed Web of Science ®Google Scholar
• Clark-Lewis, I., J. S. Sanghera, and S. L. Pelech. 1991. Definition of a consensus sequence for peptide substrate recognition by p44mpk, the meiosis-activated myelin basic protein kinase. J. Biol. Chem. 266:15180–15184.
   PubMedGoogle Scholar
• Dechend, R., F. Hirano, K. Lehmann, V. Heissmeyer, S. Ansieau, F. G. Wulczyn, C. Scheidereit, and A. Leutz. 1999. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators. Oncogene 18:3316–3323.
   PubMed Web of Science ®Google Scholar
• DeRubertis, F. R., and P. A. Craven. 1993. Eicosanoids in the pathogenesis of the functional and structural alterations of the kidney in diabetes. Am. J. Kidney Dis. 22:727–735.
   PubMedGoogle Scholar
• Di Popolo, A., A. Memoli, A. Apicella, C. Tuccillo, A. di Palma, P. Ricchi, A. M. Acquaviva, and R. Zarrilli. 2000. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells. Oncogene 19:5517–5524.
   PubMedGoogle Scholar
• Enari, M., H. Hug, M. Hayakawa, F. Ito, Y. Nishimura, and S. Nagata. 1996. Different apoptotic pathways mediated by Fas and the tumor-necrosis-factor receptor. Cytosolic phospholipase A2 is not involved in Fas-mediated apoptosis. Eur. J. Biochem. 236:533–538.
   PubMedGoogle Scholar
• Fukushima, M., T. Kato, S. Narumiya, Y. Mizushima, H. Sasaki, Y. Terashima, Y. Nishiyama, and M. G. Santoro. 1989. Prostaglandin A and J: antitumor and antiviral prostaglandins. Adv. Prostaglandin Thromboxane Leukot. Res. 19:415–418.
   PubMedGoogle Scholar
• Gietz, D., A. St. Jean, R. A. Woods, and R. H. Schiestl. 1992. Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res. 20:1425
   PubMed Web of Science ®Google Scholar
• Glover, S., M. S. de Carvalho, T. Bayburt, M. Jonas, E. Chi, C. C. Leslie, and M. H. Gelb. 1995. Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J. Biol. Chem. 270:15359–15367.
   PubMedGoogle Scholar
• Gupta, K., S. Kshirsagar, W. Li, L. Gui, S. Ramakrishnan, P. Gupta, P. Y. Law, and R. P. Hebbel. 1999. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp. Cell Res. 247:495–504.
   PubMed Web of Science ®Google Scholar
• Gyuris, J., E. Golemis, H. Chertkov, and R. Brent. 1993. Cdil, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75:791–803.
   PubMed Web of Science ®Google Scholar
• Haq, S., G. Choukroun, Z. B. Kang, H. Ranu, T. Matsui, A. Rosenzweig, J. D. Molkentin, A. Alessandrini, J. Woodgett, R. Hajjar, A. Michael, and T. Force. 2000. Glycogen synthase kinase-3 beta is a negative regulator of cardiac hypertrophy. J. Cell Biol. 151:117–130.
   PubMedGoogle Scholar
• Hayakawa, M., N. Ishida, K. Takeuchi, S. Shibamoto, T. Hori, N. Oku, F. Ito, and M. Tsujimoto. 1993. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem. 268:11290–11295.
   PubMed Web of Science ®Google Scholar
• Hayakawa, M., S. Jayadev, M. Tsujimoto, Y. A. Hannun, and F. Ito. 1996. Role of ceramide in the stimulation of the transcription of cytosolic phospholipase A2 and cycloxygenase 2. Biochem. Biophys. Res. Commun. 220:681–686.
   PubMed Web of Science ®Google Scholar
• Higashi, S., H. Ohishi, and I. Kudo. 2000. Augmented prostaglandin E2 generation resulting from increased activities of cytosolic and secretory phospholipase A2 and induction of cyclooxygenase-2 in interleukin-1 beta-stimulated rat calvarial cells during the mineralizing phase. Inflamm. Res. 49:102–111.
   PubMedGoogle Scholar
• Hilfiker, A., D. Hilfiker-Kleiner, A. Pannuti, and J. C. Lucchesi. 1997. mof, a putative acetyl transferase gene related to the Tip60 and MOZ human genes and to the SAS genes of yeast, is required for dosage compensation in Drosophila. EMBO J. 16:2054–2060.
   PubMed Web of Science ®Google Scholar
• Hoffman, C. S., and F. Winston. 1987. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 57:267–272.
   PubMed Web of Science ®Google Scholar
• Ikura, T., V. V. Ogryzko, M. Grigoriev, R. Groishman, J. Wang, M. Horikoshi, R. Scully, J. Qin, and Y. Nakatani. 2000. Involvement of the Tip60 histone acetylase complex in DNA repair and apoptosis. Cell 102:463–473.
   PubMed Web of Science ®Google Scholar
• Jayadev, S., C. M. Linardic, and Y. A. Hannun. 1994. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha. J. Biol. Chem. 269:5757–5763.
   PubMed Web of Science ®Google Scholar
• Jayadev, S., and Y. A. Hannun. 1996. Ceramide: role in growth inhibitory cascades. J. Lipid. Mediat. Cell Signal. 14:295–301.
   PubMedGoogle Scholar
• Jayadev, S., J. C. Barret, and E. Murphy. 2000. Elevated ceramide is downstream of altered calcium homeostasis in low serum-induced apoptosis. Am. J. Physiol. Cell Physiol. 279:C1640–C1647.
   PubMedGoogle Scholar
• Jayadev, S., H. L. Hayter, N. Andrieu, C. J. Gamard, B. Liu, R. Balu, M. Hayakawa, F. Ito, and Y. A. Hannun. 1997. Phospholipase A2 is necessary for tumor necrosis factor α-induced ceramide generation in L929 cells. J. Biol. Chem. 272:17196–17203.
   PubMedGoogle Scholar
• Jayadev, S., J. G. Petranka, S. K. Cheran, J. A. Biermann, J. C. Barrett, and E. Murphy. 1999. Reduced capacitative calcium entry correlates with vesicle accumulation and apoptosis. J. Biol. Chem. 274:8261–8268.
   PubMedGoogle Scholar
• Jayadev, S., B. Liu, A. E. Bielawska, J. Y. Lee, F. Nazaire, M. Y. Pushkareva, L. M. Obeid, and Y. A. Hannun. 1995. Role for ceramide in cell cycle arrest. J. Biol. Chem. 270:2047–2052.
   PubMed Web of Science ®Google Scholar
• Kamine, J., B. Elangovan, T. Subramanian, D. Coleman, and G. Chinnadurai. 1996. Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-Tat transactivator. Virology 216:357–366.
   PubMed Web of Science ®Google Scholar
• Kang, J. X., and A. Leaf. 1994. Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc. Natl. Acad. Sci. USA 91:9886–9890.
   PubMed Web of Science ®Google Scholar
• Kim, S. S., Y. M. Chen, E. O'Leary, R. Witzgall, and J. V. Bonventre. 1996. A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of the zinc finger proteins. Proc. Natl. Acad. Sci. USA 93:15299–15304.
   PubMedGoogle Scholar
• Konieczkowski, M., and J. R. Sedor. 1993. Cell-specific regulation of type II phospholipase A2 expression in rat mesangial cells. J. Clin. Investig. 92:2524–2532.
   PubMedGoogle Scholar
• Kozak, M.. 1991. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J. Biol. Chem. 266:19867–19870.
   PubMed Web of Science ®Google Scholar
• Kuwata, H., Y. Nakatani, M. Murakami, and I. Kudo. 1998. Cytosolic phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3YI fibroblasts. J. Biol. Chem. 273:1733–1740.
   PubMed Web of Science ®Google Scholar
• Leslie, C. C.. 1997. Properties and regulation of cytosolic phospholipase A2. J. Biol. Chem. 272:16709–16712.
   PubMed Web of Science ®Google Scholar
• Lin, L. L., A. Y. Lin, and J. L. Knopf. 1992. Cytosolic PLA2 is coupled to hormonally regulated release of arachidonic acid. Proc. Natl. Acad. Sci. USA 89:6147–6151.
   PubMed Web of Science ®Google Scholar
• Lo, H. H., P. Teichmann, G. Furstenberger, I. Gimenez-Conti, and S. M. Fischer. 1998. Suppression or elevation of cytosolic phospholipase A2 alters keratinocyte prostaglandin synthesis, growth and apoptosis. Cancer Res. 58:4624–4637.
   PubMedGoogle Scholar
• Mahadevan, P., R. G. Larkins, J. R. Fraser, and M. E. Dunlop. 1996. Effect of prostaglandin E2 and hyaluronan on mesangial cell proliferation. A potential contribution to glomerular hypercellularity in diabetes. Diabetes 45:44–50.
   PubMedGoogle Scholar
• Malis, C. D., P. C. Weber, A. Leaf, and J. V. Bonventre. 1990. Incorporation of marine lipids into mitochondrial membranes increases susceptibility to damage by calcium and reactive oxygen species: evidence for enhanced activation of phospholipase A2 in mitochondria enriched with n-3 fatty acids. Proc. Natl. Acad. Sci. USA 87:8845–8849.
   PubMed Web of Science ®Google Scholar
• Nalefski, E. A., L. A. Sultzman, D. M. Martin, R. W. Kriz, P. S. Towler, J. L. Knopf, and J. D. Clark. 1994. Delineation of two functionally distinct domains of cytosolic phospholipase A2, a regulatory Ca2+-dependent lipid-binding domain and a Ca2+-independent catalytic domain. J. Biol. Chem. 269:18239–18249.
   PubMed Web of Science ®Google Scholar
• Naraba, H., M. Murakami, H. Matsumoto, S. Shimbara, A. Ueno, I. Kudo, and S. Ohishi. 1998. Segregated coupling of phospholipases A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages. J Immunol. 160:2974–2982.
   PubMed Web of Science ®Google Scholar
• Nemenoff, R. A., S. Winitz, N. X. Qian, V. V. Van Putten, G. L. Johnson, and L. E. Heasley. 1993. Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J. Biol. Chem. 268:1960–1964.
   PubMed Web of Science ®Google Scholar
• Nigg, E. A.. 1991. The substrates of the cdc2 kinase. Semin. Cell Biol. 2:261–270.
   PubMedGoogle Scholar
• Nigg, E. A.. 1993. Targets of cyclin-dependent protein kinases. Curr. Opin. Cell Biol. 5:187–193.
   PubMed Web of Science ®Google Scholar
• Obeid, L. M., and Y. A. Hannun. 1995. Ceramide: a stress signal and mediator of growth suppression and apoptosis. J. Cell. Biochem. 58:191–198.
   PubMed Web of Science ®Google Scholar
• Oshima, M., J. E. Dinchuk, S. L. Kargman, H. Oshima, B. Hancock, E. Kwong, J. M. Trzaskos, J. F. Evans, and M. M. Taketo. 1996. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87:803–809.
   PubMed Web of Science ®Google Scholar
• Pfeilschifter, J., and A. Huwiler. 1997. Phospholipase A2 in mesangial cells: control mechanisms and functional importance. Exp. Nephrol. 5:189–193.
   PubMedGoogle Scholar
• Pica, F., O. Franzese, D. D'Onofrio, E. Bonmassar, C. Favalli, and E. Garaci. 1996. Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: a c-Myc-dependent and Bcl-2-independent associated pathway. J. Pharmacol. Exp. Ther. 277:1793–1800.
   PubMedGoogle Scholar
• Pricci, F., G. Pugliese, P. Mene, G. Romeo, G. Romano, G. Galli, A. Casini, C. M. Rotella, U. DiMario, and F. Pugliesi. 1996. Regulatory role of eicosanoids in extracellular matrix overproduction induced by long-term exposure to high glucose in cultured rat mesangial cells. Diabetologia 39:1055–1062.
   PubMedGoogle Scholar
• Ran, Q., and O. M. Pereira-Smith. 2000. Identification of an alternatively spliced form of the Tat interactive protein (Tip60), Tip60 (β). Gene 258:141–146.
   PubMedGoogle Scholar
• Reifsnyder, C., J. Lowell, A. Clarke, and L. Pillus. 1996. Yeast SAS silencing genes and human genes associated with AML and HIV-1 Tat interactions are homologous with acetyltransferases. Nat. Genet. 14:42–49.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y
   Google Scholar
• Sapirstein, A., R. A. Spech, R. Witzgall, and J. V. Bonventre. 1996. Cytosolic phospholipase A2 (PLA2), but not secretory PLA2, potentiates hydrogen peroxide cytotoxicity in kidney epithelial cells. J. Biol. Chem. 271:21505–21513.
   PubMed Web of Science ®Google Scholar
• Schievella, A. R., M. K. Regier, W. L. Smith, and L. L. Lin. 1995. Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum. J. Biol. Chem. 270:30749–30754.
   PubMed Web of Science ®Google Scholar
• Sierra-Honigmann, M. R., J. R. Bradley, and J. S. Pober. 1996. “Cytosolic” phospholipase A2 is in the nucleus of subconfluent endothelial cells but confined to the cytoplasm of confluent endothelial cells and redistributes to the nuclear envelope and cell junctions upon histamine stimulation. Lab. Investig. 74:684–695.
   PubMedGoogle Scholar
• Smith, E. R., A. Eisen, W. Gu, M. Sattah, A. Pannuti, J. Zhou, R. G. Cook, J. C. Lucchesi, and C. D. Allis. 1998. ESA1 is a histone acetyltransferase that is essential for growth in yeast. Proc. Natl. Acad. Sci. USA 95:3561–3565.
   PubMed Web of Science ®Google Scholar
• Songyang, Z., S. Blechner, N. Hoagland, M. F. Hoekstra, H. Piwnica-Worms, and L. C. Cantley. 1994. Use of an oriented peptide library to determine the optimal substrate of protein kinases. Curr. Biol. 4:973–982.
   PubMed Web of Science ®Google Scholar
• Spencer, A. G., J. W. Woods, T. Arakawa, I. I. Singer, and W. L. Smith. 1998. Subcellular localization of prostaglandin endoperoxide H synthase-1 and -2 by immunoelectron microscopy. J. Biol. Chem. 16:9886–9893.
   Google Scholar
• Sterner, D. E., and S. L. Berger. 2000. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64:435–459.
   PubMed Web of Science ®Google Scholar
• Sugiyama, H., N. Kashihara, Y. Maeshima, K. Okamoto, K. Kanao, T. Sekikawa, and H. Makino. 1998. Regulation of survival and death of mesangial cells by extracellular matrix. Kidney Int. 54:1188–1196.
   PubMedGoogle Scholar
• Uozumi, N., K. Kume, T. Nagase, N. Nakatani, S. Ishii, F. Tashiro, N. Komagata, K. Maki, K. Ikuta, Y. Ouchi, J. Miyazaki, and T. Shimizu. 1997. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 390:618–622.
   PubMed Web of Science ®Google Scholar
• Voelkel-Johnson, C., T. E. Thorne, and S. M. Laster. 1996. Susceptibility to TNF in the presence of inhibitors of transcription or translation is dependent on the activity of cytosolic phospholipase A2 in human melanoma tumor cells. J. Immunol. 156:201–207.
   PubMedGoogle Scholar
• Waterman, W. H., and R. I. Sha'afi. 1995. A mitogen-activated protein kinase independent pathway involved in the phosphorylation and activation of cytosolic phospholipase A2 in human neutrophils stimulated with tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 209:271–278.
   PubMedGoogle Scholar
• Wissing, D., H. Mouritzen, M. Egeblad, G. G. Poirier, and M. Jaatela. 1997. Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:5073–5077.
   PubMed Web of Science ®Google Scholar
• Woods, J. W., M. J. Coffey, T. G. Brock, I. I. Singer, and M. Peters-Golden. 1995. 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J. Clin. Investig. 95:2035–2046.
   PubMed Web of Science ®Google Scholar
• Woods, J. W., J. F. Evans, D. Ethier, S. Scott, P. J. Vickers, L. Hearn, J. A. Heibein, S. Charleson, and I. I. Singer. 1993. 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178:1935–1946.
   PubMed Web of Science ®Google Scholar
• Wu, Y. L., X. R. Jiang, A. C. Newland, and S. M. Kelsey. 1998. Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells. J. Immunol. 160:5929–5935.
   PubMedGoogle Scholar
• Yamamoto, T., and M. Horikoshi. 1997. Novel substrate specificity of the histone acetyltransferase activity of HIV-1-Tat interactive protein Tip60. J. Biol. Chem. 272:30595–30598.
   PubMed Web of Science ®Google Scholar
• Zhu, Y. X., H. B. Sun, M. L. Tsang, J. McMahel, S. Grigsby, T. Yin, and Y. C. Yang. 1997. Critical cytoplasmic domains of human interleukin-9 receptor alpha chain in interleukin-9-mediated cell proliferation and signal transduction. J. Biol. Chem. 272:21334–21340.
   PubMed Web of Science ®Google Scholar